Norfolk Southern Corporation (NYSE:NSC) shares moved down -0.35% in last trading session and ended the day at $79.87. NSC Gross Margin is 38.10% and its has a return on assets of 5.10%. Norfolk Southern Corporation (NYSE:NSC) quarterly performance is -2.62%.
Norfolk Southern Corp. (NYSE:NSC) has partnered with state and local governments to introduce a new fleet of environment- friendly rail yard locomotives for Chicago. The city plays a vital role in the company’s rail road network. The engine would be named “Eco” locomotive, because of its operating efficiencies to reduce fuel consumption and emission. The company raised more than $19 million funding from Federal Congestion Mitigation and Air quality improvement Program (CMAQ). The new units have a green paint scheme with an Illinois-shaped icon and slogan that says “Working Together for a Cleaner State.”
Insmed Incorporated (NASDAQ:INSM) ended the last trading day at $17.09. Company weekly volatility is calculated as 4.98% and price to cash ratio as 3.15. Insmed Incorporated (NASDAQ:INSM) showed a weekly performance of -13.86%.
Insmed Incorporated (NASDAQ:INSM) reported financial results for the third quarter and nine months ended September 30, 2015. For the third quarter of 2015, Insmed posted a net loss of $31.0 million, or $0.50 per share, compared with a net loss of $24.0 million, or $0.54 per share, for the third quarter of 2014. The company remains on track to submit its responses to the European Medicine Agency’s (EMA) 120-day questions before the end of 2015. The 120-day questions are part of EMA’s review of the company’s marketing authorization application (MAA) for ARIKAYCE.
On 06 November, Carolina Bank Holdings Inc. (NASDAQ:CLBH) shares moved up 0.27% and was closed at $15.10. CLBH EPS growth in last 5 year was 29.40%. Carolina Bank Holdings Inc. (NASDAQ:CLBH) year to date (YTD) performance is 56.48%.
Carolina Bank Holdings, Inc. (NASDAQ:CLBH) reported third quarter 2015. Net income of $1,436,000 in the third quarter of 2015 increased 41.9% from $1,012,000 in the third quarter of 2014. Net income for the nine months ended September 30, 2015 and September 30, 2014 was $4,731,000 and $2,027,000, respectively, an increase of 133.4% in the 2015 period.Net income available to common shareholders increased 88.0% to $1,436,000 in the third quarter of 2015 from $764,000 in the third quarter of 2014.
Repligen Corporation (NASDAQ:RGEN) shares moved down -17.20% in last trading session and ended the day at $26.81. RGEN Gross Margin is 57.10% and its has a return on assets of 5.80%. Repligen Corporation (NASDAQ:RGEN) quarterly performance is -27.76%.
Repligen Corporation (NASDAQ:RGEN), reported financial results for the third quarter and nine-month (year-to-date) periods ended September 30, 2015. Product revenue for the third quarter of 2015 was $19.8 million compared to $15.2 million for the third quarter of 2014, an increase of 31% on a GAAP basis, or 38% at constant currency. For the first nine months of 2015, product revenue was $62.1 million compared to $45.0 million for the same period in 2014, an increase of 38% on a GAAP basis, or 47% at constant currency. Total revenue for year-to-date 2015 was comprised entirely of bioprocessing product revenue. For the year-to-date period in 2014, total revenue was $47.2 million, which included payments totaling $2.1 million from BioMarin Pharmaceutical Inc. under our therapeutic asset purchase agreement.
CTI BioPharma Corp. (NASDAQ:CTIC) caters to the Healthcare space. On the last day of trading company shares ended up at $1.33. CTI BioPharma Corp. (NASDAQ:CTIC) distance from 50-day simple moving average (SMA50) is 2.19%.
CTI BioPharma Corp. (NASDAQ:CTIC) announced that data highlighting two compounds (pacritinib and tosedostat) from the company’s investigational pipeline will be presented at the upcoming 57th American Society of Hematology (ASH) Annual Meeting and Exposition, being held December 5-8 in Orlando, FL – including three oral presentations.